ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.00
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
88.165
0.00%
Bitcoin
62,924.93
-1.28%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Mustang Bio Inc (MBIO) Quote

Mustang Bio Inc

Mustang Bio Inc (MBIO)

MindBio Therapeutics Corp
0.3161
-0.0343
(-9.79%)
Closed April 26 4:00PM
Delayed by 15 minutes
0.32
0.0039
(1.23%)
After Hours: 7:59PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.32
Bid
0.31
Ask
0.3203
Volume
269,716
0.315 Day's Range 0.3699
0.315 52 Week Range 8.17
Market Cap
3.325M
Previous Close
0.3504
Open
0.3608
Last Trade
100
@
0.32
(formt)
Last Trade Time
Financial Volume
$ 88,050
VWAP
0.326456
Average Volume (3m)
222,641
Shares Outstanding
10,390,132
Dividend Yield
-
PE Ratio
-0.06
Earnings Per Share (EPS)
-4.97
Revenue
-
Net Profit
-51.6M

About Mustang Bio Inc

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for ... Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.mustangbio.com
Headquarters
Dover, Delaware, USA
Founded
1970
Mustang Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MBIO. The last closing price for Mustang Bio was $0.35. Over the last year, Mustang Bio shares have traded in a share price range of $ 0.315 to $ 8.17.

Mustang Bio currently has 10,390,132 shares outstanding. The market capitalization of Mustang Bio is $3.32 million. Mustang Bio has a price to earnings ratio (PE ratio) of -0.06.

MBIO Latest News

More News

Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases

Planning for proof-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy in autoimmune diseases is underway and expected to initiate in the...

March 28 2024
GlobeNewswire Inc.

Form 8-K - Current report

March 11 2024
Edgar (US Regulatory)

Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

WORCESTER, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s...

March 11 2024
GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

March 11 2024
Edgar (US Regulatory)

Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma

MB-101 was well-tolerated and 50% of patients achieved stable disease or better with two partial responses and two complete responses lasting 7.5 and 66+ months, respectively ~70% improvement in...

March 07 2024
GlobeNewswire Inc.

Form 8-K - Current report

February 14 2024
Edgar (US Regulatory)

Form 8-K - Current report

January 25 2024
Edgar (US Regulatory)

Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

WORCESTER, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s...

January 11 2024
GlobeNewswire Inc.

Form 8-K - Current report

January 04 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

December 19 2023
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0401-11.13579561230.36010.39990.3151521150.34604007CS
4-0.73-69.52380952381.051.060.3152683780.51657987CS
12-1.07-76.97841726621.391.490.3152226410.96524583CS
26-1.41-81.50289017341.732.110.3151601761.13566497CS
52-3.51-91.64490861623.838.170.315991191.8599889CS
156-46.33-99.314040728846.6560.90.31562868726.0539658CS
260-76.33-99.582517938776.6589.70.31584273041.47231761CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

MBIO Discussion

View Posts
Monksdream Monksdream 2 weeks ago
MBIO new 52 lo
👍️0
glenn1919 glenn1919 1 month ago
MBIO.................................https://stockcharts.com/h-sc/ui?s=MBIO&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 month ago
MBIO new 52 week lo
👍️0
Monksdream Monksdream 2 months ago
Already read it earlier this morning
👍️0
subslover subslover 2 months ago
City of Hope-developed Chimeric Antigen Receptor (CAR) T Cell Therapy Shows Clinical Activity in Patients With Aggressive Brain Tumors in a Phase 1 Trial
the study, which is the largest reported trial to date of CAR T therapy for solid tumors, evaluated CAR T cells engineered to target the tumor-associated antigen interleukin-13 receptor alpha 2 (IL13Ra2), a product invented at City of Hope and exclusively licensed by Mustang Bio Inc. (Nasdaq: MBIO), a Fortress Biotech Inc. (Nasdaq: FBIO) Company.
https://www.businesswire.com/news/home/20240307463963/en/
👍️0
Monksdream Monksdream 2 months ago
Probably new caused the run
👍️0
Monksdream Monksdream 2 months ago
MBIO under $2
👍️0
Monksdream Monksdream 4 months ago
MBIO new 52 week low
👎️ 1 🤡 1 🩳 1
Monksdream Monksdream 6 months ago
Three or four years ago stocks of clinical trial biomed companies could do no wrong
Institutional asset managers accumulated large amounts of shares and continued buying even though most sold more shares to raise more money to replace the money they burned through
When the US central bank raised interest rates the asset managers started selling these shares
This will continue until the US central bank reverses course and begins lowering interest rates
👍️0
ipo_dude ipo_dude 6 months ago
Nothing a POS
👍️0
Monksdream Monksdream 6 months ago
MBIO new 52=week low
👍️0
Monksdream Monksdream 7 months ago
MBIO new 52 week low
👍️0
zeusgodmd zeusgodmd 1 year ago
Reverse may be coming to get institutional investors back
👍️0
zeusgodmd zeusgodmd 1 year ago
She going to pop soon
👍️0
zeusgodmd zeusgodmd 1 year ago
Giddie up horse
👍️0
zeusgodmd zeusgodmd 1 year ago
It will happen just like jasper
👍️0
zeusgodmd zeusgodmd 1 year ago
Double down today. We’ll see if she gets sold to the highest bidder
👍️0
zeusgodmd zeusgodmd 2 years ago
Blackrock upped there shares this week
👍️0
SmallCapStockGuy SmallCapStockGuy 2 years ago
MBIO this week?

Best Penny Stocks To Buy? 5 To Watch With Potential Catalysts This Week
👍️0
jerseyboy jerseyboy 3 years ago
A $200 million mixed shelf offering does not bode well for the share price tomorrow. Historically, the market has not reacted well to the potential dilution when the company has gone to the market for more money.
👍️0
zeusgodmd zeusgodmd 3 years ago
Looks like it was black rock picking up chunks of shares last week
👍️0
zeusgodmd zeusgodmd 3 years ago
Good luck to ya
👍️0
jerseyboy jerseyboy 3 years ago
It's a really good stock and company - it was unfortunate that I found another that I consider to be more revolutionary in the long term to which I needed to assign the capital at a temporarily low and very favorable price (NVTA).
👍️0
zeusgodmd zeusgodmd 3 years ago
CEO has bought and holding a ton is a good sign maybe should have held I think it will continue the climb has too many drugs in there pipeline will see above 10 this year it’s a buy and hold
👍️0
jerseyboy jerseyboy 3 years ago
I very sadly said goodbye to my beloved Mustang this morning at a slight profit in order to buy another stock whose price had just become too attractive and has disruptive prospects in its industry (NVTA). This is still a very promising company and I may yet return when I have more investment capital, but for now I had to leave. I think any buyer will be pleased in the long run if they buy Mustang at this price.
👍️0
jerseyboy jerseyboy 3 years ago
And still the price keeps steadily advancing. What a shame so few investors are paying attention.
👍️0
jerseyboy jerseyboy 3 years ago
The stock price just keeps on advancing. This quality company is one of the best small biopharmas around, yet very few investors seem to be aware of its existence.
👍️0
jerseyboy jerseyboy 3 years ago
This has just capped off a great week. In the long run this will trade much higher than what it is trading at now.
👍️0
jerseyboy jerseyboy 3 years ago
Good news and a nice increase today. This well-managed company has really good long-term potential.
👍️0
jerseyboy jerseyboy 3 years ago
That's because people are afraid of the potential dilution from the $100 million stock filing. All I can say is that if Manny Lichtman was willing to pay $3.25 for this back in the spring, I have confidence in buying anywhere below that, and I believe they have a pipeline that will prove to be worth far more than where it is trading now in a couple of years.
👍️0
willlbone willlbone 3 years ago
Setting themselves up for major dilution. Sell
👍️0
Dragonfly79 Dragonfly79 3 years ago
I don’t get it, they getting all high buy ratings from everywhere. Everytime good news comes out it sells off
👍️0
weedtrader420 weedtrader420 3 years ago
MBIO $10 TARGET PRICE TODAY WOOHOOOOOOOOOO
👍️0
jerseyboy jerseyboy 3 years ago
This keeps moving up slowly but surely - I think this has some of the best long-term prospects in small cap biopharma.
👍️0
jerseyboy jerseyboy 3 years ago
They'll need to sell more shares as time goes on, but that's because they have significant needs to fund all the areas of the business that have great potential. I think these people know what they're doing, and they have heavyweight backing. I think the stock price will be much higher in five years than where it is now, and I'm willing to hold long to see how they will develop the business.
👍️0
jonsmile jonsmile 4 years ago
More dilution I see after the bell down she goes
👍️0
TFMG TFMG 4 years ago
$MBIO | #MustangBio Bullish MA Breakout

Friday brought a significant break from a 200 & 100 MA channel.
Possible Gap fill to $4.18
Major pivot target $4.85
RSI crossed mid point
MACD bullish cross and reversal.
Histogram bullish above Zero-line





👍️0
ClayTrader ClayTrader 4 years ago
* * $MBIO Video Chart 05-26-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 5 years ago
* * $MBIO Video Chart 04-30-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
TeddyCaswell TeddyCaswell 5 years ago
Lol I never seen it spread out like that.
👍️0
BillG2436 BillG2436 5 years ago
I see there was a 911 trade this morning. PR/News today maybe.
👍️0
TeddyCaswell TeddyCaswell 5 years ago
Looks like it
👍️0
BillG2436 BillG2436 5 years ago
Looks like bubble boy may burst. Could see $7+ today
👍️0
ClayTrader ClayTrader 5 years ago
* * $MBIO Video Chart 04-22-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
BillG2436 BillG2436 5 years ago
This has been all over the news this past week. It will be interesting to see how the stock price reacts this week. Appears this is a cure for bubble boy disease. The question remains is how many suffer from this disease and what is the potential revenue moving forward?
👍️0
gregque gregque 5 years ago
👍️0
gregque gregque 5 years ago
👍️0
gregque gregque 5 years ago
this news was on NBC nightly news on the 17th
👍️0
ClayTrader ClayTrader 5 years ago
* * $MBIO Video Chart 04-18-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
BillG2436 BillG2436 5 years ago
One analyst and he’s been know to drink a few while making these predictions. He 50/50 at best
👍️0

Your Recent History

NASDAQ
MBIO
Mustang Bio
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved